Cirrhotic patients with hepatocellular carcinoma (HCC) frequently develop hepatic encephalopathy. Metabolic etiology of encephalopathy is less often considered in these patients. Although paraneoplastic hypercalcemia may be associated with several malignant tumors, it has also been described in HCC [1, 2, 3, 4], and may cause neurologic disturbances. We present a case of hypercalcemic encephalopathy in a patient with hepatic cirrhosis and underlying HCC in whom first diagnostic was hepatic encephalopathy.
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Leone N, Debernardi-Venon W, Marzano A, Massari M, Rizzetto M (1999) Hypercalcemia secondary to hepatocellular carcinoma. Ital J Gastroenterol Hepatol 31:604–606PubMedGoogle Scholar
Pun KK, Tam SM (1995) Humoral hypercalcemia of hepatocellular carcinoma associated with elevated levels of parathyroid-hormone-related-peptide. Endocr Pract 1:166–169PubMedGoogle Scholar
Ghobrial MW, George J, Mannam S, Henien SR (2002) Severe hypercalcemia as an initial presenting manifestation of hepatocellular carcinoma. Can J Gastroenterol 16:607–609PubMedGoogle Scholar
Tamura K, Kubota K, Yake H, Kurabayashi H, Shirakura T (1994) Parathyroid hormone-related peptide as a possible cause of hypercalcemia in a hepatocellular carcinoma patient. Am J Gastroenterol 89:644–645PubMedGoogle Scholar